Values First Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History

Values First Advisors’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-52,012	Closed	-$252K	–	146
2020 Q1	$252K	Buy	52,012 +19,983	+62%	+$130K	0.3%	97
2019 Q4	$340K	Buy	+32,029	New	+$318K	0.33%	91

Values First Advisors's STML Position: Q2 2020 in Review

Values First Advisors sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 52,012 shares — an estimated $252K sold.

Values First Advisors first reported a position in STML in Q4 2019 and held it in 2 quarters. The position peaked at $340K in Q4 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Values First Advisors reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Values First Advisors sold 52,012 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $252K.
Values First Advisors first reported a position in Stemline Therapeutics, Inc. in Q4 2019 and held it in 2 quarters.
Values First Advisors's Stemline Therapeutics, Inc. position peaked at $340K in Q4 2019.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Values First Advisors's 13F filing for Q2 2020, filed 15 Nov 2022.